362 related articles for article (PubMed ID: 18990939)
21. BCS class IV drugs: Highly notorious candidates for formulation development.
Ghadi R; Dand N
J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
[TBL] [Abstract][Full Text] [Related]
22. Patent review of novel nanostructrued devices, nanofabrication methods and applications in nanofluidics and nanomedicine.
Michael Chen CY
Recent Pat Nanotechnol; 2012 Jun; 6(2):114-23. PubMed ID: 22181669
[TBL] [Abstract][Full Text] [Related]
23. Nanostructured silicon particles for medical applications.
Kleps I; Ignat T; Miu M; Craciunoiu F; Trif M; Simion M; Bragaru A; Dinescu A
J Nanosci Nanotechnol; 2010 Apr; 10(4):2694-700. PubMed ID: 20355486
[TBL] [Abstract][Full Text] [Related]
24. Polymeric nano-assemblies as emerging delivery carriers for therapeutic applications: a review of recent patents.
Zhang J; Li S; Li X
Recent Pat Nanotechnol; 2009; 3(3):225-31. PubMed ID: 19958285
[TBL] [Abstract][Full Text] [Related]
25. Drug nanocrystals: Fabrication methods and promising therapeutic applications.
Mohammad IS; Hu H; Yin L; He W
Int J Pharm; 2019 May; 562():187-202. PubMed ID: 30851386
[TBL] [Abstract][Full Text] [Related]
26. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
Thakkar S; Shah V; Misra M; Kalia K
Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
[TBL] [Abstract][Full Text] [Related]
27. State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.
Müller RH; Gohla S; Keck CM
Eur J Pharm Biopharm; 2011 May; 78(1):1-9. PubMed ID: 21266197
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of surface modified mesoporous materials via co-assemble route and their drug release properties.
Wang Y; Zhu J; Han J; Guo R
J Nanosci Nanotechnol; 2009 Nov; 9(11):6700-9. PubMed ID: 19908587
[TBL] [Abstract][Full Text] [Related]
29. Novel bioactive scaffolds incorporating nanogels as potential drug eluting devices.
Saez-Martinez V; Olalde B; Juan MJ; Jurado MJ; Garagorri N; Obieta I
J Nanosci Nanotechnol; 2010 Apr; 10(4):2826-32. PubMed ID: 20355508
[TBL] [Abstract][Full Text] [Related]
30. Nanostructure-mediated drug delivery.
Hughes GA
Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
[TBL] [Abstract][Full Text] [Related]
31. Biomacromolecules based core/shell architecture toward biomedical applications.
Cui W; Wang A; Zhao J; Li J
Adv Colloid Interface Sci; 2016 Nov; 237():43-51. PubMed ID: 27773338
[TBL] [Abstract][Full Text] [Related]
32. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery.
Namiki Y; Namiki T; Yoshida H; Ishii Y; Tsubota A; Koido S; Nariai K; Mitsunaga M; Yanagisawa S; Kashiwagi H; Mabashi Y; Yumoto Y; Hoshina S; Fujise K; Tada N
Nat Nanotechnol; 2009 Sep; 4(9):598-606. PubMed ID: 19734934
[TBL] [Abstract][Full Text] [Related]
33. Protein-inspired multilayer nanofilms: science, technology and medicine.
Haynie DT; Zhang L; Zhao W; Rudra JS
Nanomedicine; 2006 Sep; 2(3):150-7. PubMed ID: 17292137
[TBL] [Abstract][Full Text] [Related]
34. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
Shegokar R; Müller RH
Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
[TBL] [Abstract][Full Text] [Related]
35. Nanocarrier stimuli-activated gene delivery.
Howard KA; Dong M; Oupicky D; Bisht HS; Buss C; Besenbacher F; Kjems J
Small; 2007 Jan; 3(1):54-7. PubMed ID: 17294468
[No Abstract] [Full Text] [Related]
36. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
37. Nanocrystals Technology for Pharmaceutical Science.
Cheng Z; Lian Y; Kamal Z; Ma X; Chen J; Zhou X; Su J; Qiu M
Curr Pharm Des; 2018; 24(21):2497-2507. PubMed ID: 29773056
[TBL] [Abstract][Full Text] [Related]
38. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
39. Nanomedicine: nanocarriers shape up for long life.
Nishiyama N
Nat Nanotechnol; 2007 Apr; 2(4):203-4. PubMed ID: 18654260
[No Abstract] [Full Text] [Related]
40. Analysis of protein physical stability in lipid based delivery systems--the challenges of lipid drug delivery systems.
Jorgensen L; Martins S; van de Weert M
J Biomed Nanotechnol; 2009 Aug; 5(4):401-8. PubMed ID: 20055086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
